EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery

Sathapana Kongsamut, Haifeng Eishingdrelo

Drug Discovery Today · 2023

DOI: 10.1016/j.drudis.2023.103641 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Discovery Today, 2023. Verfasst von Sathapana Kongsamut und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Scientists Emeriti, Drew University, 36 Madison Avenue, Madison, NJ 07940, USA. Hauptthemen laut MEDLINE: 14-3-3 Proteins, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of G-protein-coupled receptors (GPCRs) triggers a series of protein-protein interaction events that subsequently induce a chain of reactions, including alteration of receptor structures, phosphorylation, recruitment of associated proteins, protein trafficking and gene expression. Multiple GPCR signaling transduction pathways are evident - two well-studied pathways are the GPCR-mediated G-protein and β-arrestin pathways. Recently, ligand-induced interactions between GPCRs and 14-3-3 proteins have been demonstrated. This linking of GPCRs to 14-3-3 protein signal hubs opens up a whole new realm of signal transduction possibilities. 14-3-3 proteins play a key part in GPCR trafficking and signal transduction. GPCR-mediated 14-3-3 protein signaling can be harnessed for the study of GPCR function and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

14-3-3 ProteinsSignal TransductionReceptors, G-Protein-Coupledbeta-ArrestinsDrug Discovery

Substanzen

14-3-3 ProteinsReceptors, G-Protein-Coupledbeta-Arrestins

Autor:innen und Institutionen

  • Research Institute for Scientists Emeriti, Drew University, 36 Madison Avenue, Madison, NJ 07940, USA.
  • BioInvenu, 50 Williams Parkway, Unit A2, East Hanover, NJ 07936, USA. Electronic address: haifeng.eishingdrelo@bioinvenu.com.

Förderung

  • NIDA NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Kongsamut, S., & Eishingdrelo, H. (2023). Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2023.103641

Vancouver

Kongsamut S, Eishingdrelo H. Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery. Drug Discovery Today. 2023. doi:10.1016/j.drudis.2023.103641

BibTeX
@article{Kongsamut2023,
  author = {Kongsamut, Sathapana and Eishingdrelo, Haifeng},
  title = {Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery},
  journal = {Drug Discovery Today},
  year = {2023},
  doi = {10.1016/j.drudis.2023.103641}
}
Kostenlos starten →